Professor Sarah Kummerfeld is the Chief Scientific Officer at the Garvan Institute of Medical Research. She oversees Garvan's scientific platforms leveraging genomics, single-cell technology, data science, imaging, and clinical translation to push technological boundaries both in the lab and through machine learning/AI. Sarah's background is in computational biology and bioinformatics.

She completed her PhD in Computational Biology at the University of Cambridge, working on protein structure and function prediction. Her postdoctoral research at Stanford University studied the molecular basis of human ageing.

Sarah has worked both in academia and industry, including 10 years as a Scientist at Genentech, based in the San Francisco Bay Area. At Genentech, she used large-scale genomics approaches to understand why only some patients respond to treatment and to identify diagnostic biomarkers that predict response to particular drugs. Sarah is dedicated to bringing applying advances in genomics research to benefit patients.